Odyssey Health Files S-1 for Continuous Public Offering

TL;DR

**ODYY's S-1 filing is a green light for future capital raises, but without financials, it's a speculative bet on their medical device pipeline.**

AI Summary

Odyssey Health, Inc. (ODYY) filed an S-1 registration statement on August 5, 2025, for a proposed sale of securities to the public on a delayed or continuous basis, indicating a potential capital raise. The company, incorporated in Nevada with a primary SIC code of 3841 (Surgical & Medical Instruments & Apparatus), operates from Las Vegas, NV. While specific revenue and net income figures are not detailed in the provided excerpt, the filing signals a strategic move to access public markets for funding. Joseph Michael Redmond serves as President and CEO, overseeing the company's operations. The S-1 filing itself does not disclose financial performance, but rather the intent to register securities for future offerings. The company's business address is 2300 West Sahara Avenue, Suite 800-#4012, Las Vegas, NV 89102, and its phone number is 702-780-6559. This registration is a foundational step for Odyssey Health to potentially expand its medical instrument and apparatus business.

Why It Matters

This S-1 filing by Odyssey Health, Inc. (ODYY) is a critical step for the company to potentially raise capital, which could fund research, development, or market expansion in the competitive surgical and medical instruments sector. For investors, it signals a future opportunity to participate in the company's growth, though the lack of immediate financial details means due diligence will be paramount. Employees might see this as a sign of stability and potential expansion, while customers could benefit from increased innovation and product availability. In the broader market, this filing adds another player seeking public funding in the medical device space, intensifying competition with established firms like Medtronic and Johnson & Johnson.

Risk Assessment

Risk Level: medium — The risk level is medium because while the S-1 indicates a strategic move to raise capital, the provided excerpt lacks specific financial performance data, such as revenue, net income, or debt levels. This absence of concrete financial metrics makes it difficult to assess the company's current health and future prospects, increasing investor uncertainty. The filing is for a 'delayed or continuous basis,' which means the timing and terms of any offering are not yet fixed, adding another layer of unpredictability.

Analyst Insight

Investors should monitor ODYY for subsequent filings that will provide detailed financial statements and offering terms. Do not invest based solely on this S-1; wait for the prospectus to understand the company's valuation, use of proceeds, and comprehensive risk factors before making any investment decisions.

Executive Compensation

Key Numbers

• 3841 — SIC Code (Indicates the company operates in Surgical & Medical Instruments & Apparatus, a key sector for its business.)
• 2025-08-05 — Filing Date (Marks the official submission of the S-1 registration statement to the SEC.)
• 333-289233 — SEC File Number (Unique identifier for this specific S-1 registration statement, allowing for tracking.)
• 702-780-6559 — Business Phone (Direct contact number for Odyssey Health, Inc.'s principal executive offices.)
• 2300 West Sahara Avenue, Suite 800-#4012, Las Vegas, NV 89102 — Business Address (Principal executive offices location, indicating operational base.)

Key Players & Entities

• Odyssey Health, Inc. (company) — Registrant for S-1 filing
• Joseph Michael Redmond (person) — President and Chief Executive Officer of Odyssey Health, Inc.
• Joshua D. Brinen (person) — Attorney at Brinen & Associates, LLC, representing Odyssey Health, Inc.
• Brinen & Associates, LLC (company) — Legal counsel for Odyssey Health, Inc.
• SEC (regulator) — Securities and Exchange Commission
• Nevada (regulator) — State of incorporation for Odyssey Health, Inc.
• 3841 (regulator) — Primary Standard Industrial Classification Code for Surgical & Medical Instruments & Apparatus
• 2025-08-05 (date) — Filed as of date for the S-1
• 702-780-6559 (dollar_amount) — Business phone number for Odyssey Health, Inc.
• 333-289233 (dollar_amount) — SEC File Number for the S-1 registration statement

FAQ

Industry Context

Odyssey Health operates within the Surgical & Medical Instruments & Apparatus sector (SIC 3841). This industry is characterized by innovation, regulatory oversight, and a competitive landscape driven by technological advancements and healthcare demand. Companies in this space often focus on developing, manufacturing, and distributing devices used in medical procedures and patient care.

Regulatory Implications

As a company filing an S-1, Odyssey Health is subject to the stringent disclosure requirements of the Securities Act of 1933 and ongoing SEC regulations. Compliance with these rules is critical for maintaining market access and investor confidence.

What Investors Should Do

1. Monitor SEC Filings
2. Research Management Team
3. Analyze Business Model and Market

Key Dates

• 2025-08-05: S-1 Registration Statement Filed — This marks the official submission of the company's intent to offer securities to the public, initiating the process for a potential capital raise.
• 2014-11-28: Name Change — The company was formerly known as Odyssey Group International, Inc., indicating a rebranding or strategic shift prior to this filing.

Glossary

S-1 Registration Statement

A form filed with the U.S. Securities and Exchange Commission (SEC) by companies planning to offer their securities to the public. It provides detailed information about the company's business, financial condition, and management. (This is the foundational document for Odyssey Health's potential public offering, signaling their intent to raise capital and providing investors with essential disclosure.)

SIC Code 3841

Standard Industrial Classification code for Surgical & Medical Instruments & Apparatus. This code categorizes companies based on their primary business activities. (Indicates Odyssey Health operates within the medical device sector, specifically in the manufacturing or distribution of surgical and medical instruments.)

Rule 415

SEC rule that permits companies to register securities for sale on a delayed or continuous basis, often referred to as 'shelf registration'. (The filing indicates that securities may be offered on a delayed or continuous basis, suggesting flexibility in how Odyssey Health plans to access capital markets.)

Year-Over-Year Comparison

This is the initial S-1 filing, so a direct comparison of key metrics like revenue growth, margin changes, or financial health against a previous filing is not possible at this stage. The filing primarily signals the company's intent to enter the public markets for capital raising.

Filing Details

This Form S-1 (Form S-1) was filed with the SEC on August 5, 2025 by Joseph Michael Redmond regarding Odyssey Health, Inc. (ODYY).

View full filing on EDGAR

View Full Filing

View this S-1 filing on SEC EDGAR